glp 1 agonists drug class How should we approach patients on #GLP1 agonists? Check out this excellent editorial from Dr. Girish Joshi, "Clarifying the Guidelines and Decoding the Enigma: Strategies for Anesthetic Management of Patients on Glucagon-Like GLP-1 medications were first introduced

Results typically become noticeable within a few weeks, depending on the specific peptide used and individual response

Second, ferroptosis-modulating tools with precise spatial and temporal control should be developed, such as nanodelivery systems activated by local microenvironmental features (e.g., pH, reactive oxygen species), to avoid off-target toxicity in healthy neural tissue

Carefully developed anti-aging formulas provide support for anti-aging nutrition, ensuring the body receives essential nutrients to maintain energy and vitality throughout the day

Sensitivity analysis demonstrated no evidence of the impact of a single study on the results

Excess weight, particularly around the abdomen, can increase intra-abdominal pressure, which may in turn affect the function of the upper and lower esophageal sphincters